chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Areflexia, Blood test, Diplopia, Lumbar puncture, Magnetic resonance imaging
Clinical narrative: Vaccine not given by this facility, so no lot number on record. Report is being entered on behalf of neurologist   "As per the patient and his wife he had his COVID vaccine (Pfizer) on 4/6, 2 weeks prior to that he had cold sore breakout on his upper lip,  worse than usual. Previously breakouts were once a year or every other year. He thought that it was stress related. He had increased stool freq 2 x a day and more urgency. Has been training for marathon.  Has not had any BM for 3 days.    On 4/24 he left for a trip and things progressed so he returned on 4/26. He then noted worsening tingling, double vision, he couldn't urinate (started 4/24). On 4/24 he started having abdominal pain and presented to the local emergency room and was found to have bladder distention.  Foley catheter was placed revealing 2 L of urine. The patient then flew home and came straight to the ER.   On admission patient had MRI which noted a demyelinating process and also had a lumbar puncture with CSF noted to be lymphocytic predominant. CSF culture remained negative. PCR was negative. He was also worked up by neurology with concern for possible myeloradiculitis which based on the patient's clinical presentation would fit the diagnosis despite a negative HSV PCR.  Treatment for this is a 14-21 days of IV acyclovir. He showed continued improvement and was discharged on Acyclovir 10 mg/kg IV q.8 hours with anticipated last dose on:  5/12 or 5/19.   5.12 he has completed 14 days of IV acyclovir. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He is tolerating IV acyclovir with no adverse effects. He has had follow up with urology and his PCP. He has not had a follow up with neurology yet.   Clinically he has completed 14 days of IV acyclovir. WBC has normalized. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He has not had a follow up with neurology yet. He was looking for referral from his pcp to outside neurology but Dr popped in to say hi and mentioned he would try to reach out to Dr  to facilitate follow up here.  Will continue IV acyclovir for the entire 21 days until 5/19/21 Assessment: 1. Post viral myelitis:  Possible myeloradiculitis  2. Possible transverse myelitis   3. Urinary retention, resolved  4. Lower extremity numbness and tingling sensation:  Improved   5. History of HSV  6. Immunocompromised
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myelitis transverse, Paraesthesia, Spinal cord injury, Urinary retention, X-ray
Clinical narrative: Vaccine not given by this facility, so no lot number on record. Report is being entered on behalf of neurologist   "As per the patient and his wife he had his COVID vaccine (Pfizer) on 4/6, 2 weeks prior to that he had cold sore breakout on his upper lip,  worse than usual. Previously breakouts were once a year or every other year. He thought that it was stress related. He had increased stool freq 2 x a day and more urgency. Has been training for marathon.  Has not had any BM for 3 days.    On 4/24 he left for a trip and things progressed so he returned on 4/26. He then noted worsening tingling, double vision, he couldn't urinate (started 4/24). On 4/24 he started having abdominal pain and presented to the local emergency room and was found to have bladder distention.  Foley catheter was placed revealing 2 L of urine. The patient then flew home and came straight to the ER.   On admission patient had MRI which noted a demyelinating process and also had a lumbar puncture with CSF noted to be lymphocytic predominant. CSF culture remained negative. PCR was negative. He was also worked up by neurology with concern for possible myeloradiculitis which based on the patient's clinical presentation would fit the diagnosis despite a negative HSV PCR.  Treatment for this is a 14-21 days of IV acyclovir. He showed continued improvement and was discharged on Acyclovir 10 mg/kg IV q.8 hours with anticipated last dose on:  5/12 or 5/19.   5.12 he has completed 14 days of IV acyclovir. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He is tolerating IV acyclovir with no adverse effects. He has had follow up with urology and his PCP. He has not had a follow up with neurology yet.   Clinically he has completed 14 days of IV acyclovir. WBC has normalized. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He has not had a follow up with neurology yet. He was looking for referral from his pcp to outside neurology but Dr popped in to say hi and mentioned he would try to reach out to Dr  to facilitate follow up here.  Will continue IV acyclovir for the entire 21 days until 5/19/21 Assessment: 1. Post viral myelitis:  Possible myeloradiculitis  2. Possible transverse myelitis   3. Urinary retention, resolved  4. Lower extremity numbness and tingling sensation:  Improved   5. History of HSV  6. Immunocompromised
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Bladder catheterisation, Bowel movement irregularity, C-reactive protein normal, CSF culture negative
Clinical narrative: Vaccine not given by this facility, so no lot number on record. Report is being entered on behalf of neurologist   "As per the patient and his wife he had his COVID vaccine (Pfizer) on 4/6, 2 weeks prior to that he had cold sore breakout on his upper lip,  worse than usual. Previously breakouts were once a year or every other year. He thought that it was stress related. He had increased stool freq 2 x a day and more urgency. Has been training for marathon.  Has not had any BM for 3 days.    On 4/24 he left for a trip and things progressed so he returned on 4/26. He then noted worsening tingling, double vision, he couldn't urinate (started 4/24). On 4/24 he started having abdominal pain and presented to the local emergency room and was found to have bladder distention.  Foley catheter was placed revealing 2 L of urine. The patient then flew home and came straight to the ER.   On admission patient had MRI which noted a demyelinating process and also had a lumbar puncture with CSF noted to be lymphocytic predominant. CSF culture remained negative. PCR was negative. He was also worked up by neurology with concern for possible myeloradiculitis which based on the patient's clinical presentation would fit the diagnosis despite a negative HSV PCR.  Treatment for this is a 14-21 days of IV acyclovir. He showed continued improvement and was discharged on Acyclovir 10 mg/kg IV q.8 hours with anticipated last dose on:  5/12 or 5/19.   5.12 he has completed 14 days of IV acyclovir. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He is tolerating IV acyclovir with no adverse effects. He has had follow up with urology and his PCP. He has not had a follow up with neurology yet.   Clinically he has completed 14 days of IV acyclovir. WBC has normalized. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He has not had a follow up with neurology yet. He was looking for referral from his pcp to outside neurology but Dr popped in to say hi and mentioned he would try to reach out to Dr  to facilitate follow up here.  Will continue IV acyclovir for the entire 21 days until 5/19/21 Assessment: 1. Post viral myelitis:  Possible myeloradiculitis  2. Possible transverse myelitis   3. Urinary retention, resolved  4. Lower extremity numbness and tingling sensation:  Improved   5. History of HSV  6. Immunocompromised
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diplopia, Gait disturbance, HIV test negative, Hypoaesthesia, Lumbar puncture
Clinical narrative: Vaccine not given by this facility, so no lot number on record. Report is being entered on behalf of neurologist   "As per the patient and his wife he had his COVID vaccine (Pfizer) on 4/6, 2 weeks prior to that he had cold sore breakout on his upper lip,  worse than usual. Previously breakouts were once a year or every other year. He thought that it was stress related. He had increased stool freq 2 x a day and more urgency. Has been training for marathon.  Has not had any BM for 3 days.    On 4/24 he left for a trip and things progressed so he returned on 4/26. He then noted worsening tingling, double vision, he couldn't urinate (started 4/24). On 4/24 he started having abdominal pain and presented to the local emergency room and was found to have bladder distention.  Foley catheter was placed revealing 2 L of urine. The patient then flew home and came straight to the ER.   On admission patient had MRI which noted a demyelinating process and also had a lumbar puncture with CSF noted to be lymphocytic predominant. CSF culture remained negative. PCR was negative. He was also worked up by neurology with concern for possible myeloradiculitis which based on the patient's clinical presentation would fit the diagnosis despite a negative HSV PCR.  Treatment for this is a 14-21 days of IV acyclovir. He showed continued improvement and was discharged on Acyclovir 10 mg/kg IV q.8 hours with anticipated last dose on:  5/12 or 5/19.   5.12 he has completed 14 days of IV acyclovir. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He is tolerating IV acyclovir with no adverse effects. He has had follow up with urology and his PCP. He has not had a follow up with neurology yet.   Clinically he has completed 14 days of IV acyclovir. WBC has normalized. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He has not had a follow up with neurology yet. He was looking for referral from his pcp to outside neurology but Dr popped in to say hi and mentioned he would try to reach out to Dr  to facilitate follow up here.  Will continue IV acyclovir for the entire 21 days until 5/19/21 Assessment: 1. Post viral myelitis:  Possible myeloradiculitis  2. Possible transverse myelitis   3. Urinary retention, resolved  4. Lower extremity numbness and tingling sensation:  Improved   5. History of HSV  6. Immunocompromised
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Magnetic resonance imaging spinal normal, Paraesthesia, Red blood cell sedimentation rate increased, Treponema test negative
Clinical narrative: Vaccine not given by this facility, so no lot number on record. Report is being entered on behalf of neurologist   "As per the patient and his wife he had his COVID vaccine (Pfizer) on 4/6, 2 weeks prior to that he had cold sore breakout on his upper lip,  worse than usual. Previously breakouts were once a year or every other year. He thought that it was stress related. He had increased stool freq 2 x a day and more urgency. Has been training for marathon.  Has not had any BM for 3 days.    On 4/24 he left for a trip and things progressed so he returned on 4/26. He then noted worsening tingling, double vision, he couldn't urinate (started 4/24). On 4/24 he started having abdominal pain and presented to the local emergency room and was found to have bladder distention.  Foley catheter was placed revealing 2 L of urine. The patient then flew home and came straight to the ER.   On admission patient had MRI which noted a demyelinating process and also had a lumbar puncture with CSF noted to be lymphocytic predominant. CSF culture remained negative. PCR was negative. He was also worked up by neurology with concern for possible myeloradiculitis which based on the patient's clinical presentation would fit the diagnosis despite a negative HSV PCR.  Treatment for this is a 14-21 days of IV acyclovir. He showed continued improvement and was discharged on Acyclovir 10 mg/kg IV q.8 hours with anticipated last dose on:  5/12 or 5/19.   5.12 he has completed 14 days of IV acyclovir. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He is tolerating IV acyclovir with no adverse effects. He has had follow up with urology and his PCP. He has not had a follow up with neurology yet.   Clinically he has completed 14 days of IV acyclovir. WBC has normalized. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He has not had a follow up with neurology yet. He was looking for referral from his pcp to outside neurology but Dr popped in to say hi and mentioned he would try to reach out to Dr  to facilitate follow up here.  Will continue IV acyclovir for the entire 21 days until 5/19/21 Assessment: 1. Post viral myelitis:  Possible myeloradiculitis  2. Possible transverse myelitis   3. Urinary retention, resolved  4. Lower extremity numbness and tingling sensation:  Improved   5. History of HSV  6. Immunocompromised
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urinary retention, Viral myelitis, West Nile virus test negative
Clinical narrative: Vaccine not given by this facility, so no lot number on record. Report is being entered on behalf of neurologist   "As per the patient and his wife he had his COVID vaccine (Pfizer) on 4/6, 2 weeks prior to that he had cold sore breakout on his upper lip,  worse than usual. Previously breakouts were once a year or every other year. He thought that it was stress related. He had increased stool freq 2 x a day and more urgency. Has been training for marathon.  Has not had any BM for 3 days.    On 4/24 he left for a trip and things progressed so he returned on 4/26. He then noted worsening tingling, double vision, he couldn't urinate (started 4/24). On 4/24 he started having abdominal pain and presented to the local emergency room and was found to have bladder distention.  Foley catheter was placed revealing 2 L of urine. The patient then flew home and came straight to the ER.   On admission patient had MRI which noted a demyelinating process and also had a lumbar puncture with CSF noted to be lymphocytic predominant. CSF culture remained negative. PCR was negative. He was also worked up by neurology with concern for possible myeloradiculitis which based on the patient's clinical presentation would fit the diagnosis despite a negative HSV PCR.  Treatment for this is a 14-21 days of IV acyclovir. He showed continued improvement and was discharged on Acyclovir 10 mg/kg IV q.8 hours with anticipated last dose on:  5/12 or 5/19.   5.12 he has completed 14 days of IV acyclovir. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He is tolerating IV acyclovir with no adverse effects. He has had follow up with urology and his PCP. He has not had a follow up with neurology yet.   Clinically he has completed 14 days of IV acyclovir. WBC has normalized. He notes that diplopia and urinary retention have resolved. He no longer requires catheterization. He is working with PT and his gait and paraesthesias have improved. He has not had a follow up with neurology yet. He was looking for referral from his pcp to outside neurology but Dr popped in to say hi and mentioned he would try to reach out to Dr  to facilitate follow up here.  Will continue IV acyclovir for the entire 21 days until 5/19/21 Assessment: 1. Post viral myelitis:  Possible myeloradiculitis  2. Possible transverse myelitis   3. Urinary retention, resolved  4. Lower extremity numbness and tingling sensation:  Improved   5. History of HSV  6. Immunocompromised
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Eye pain, Gait disturbance, Headache, Hypoaesthesia
Clinical narrative: Left arm hurt at injection site; Whole arm hurt; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb/Left side of face feels kind of numb; Left leg felt tingly now it feels weak and numb; Left eye is blurrier than normal; Left eye is blurrier than normal; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0170), via an unspecified route of administration in left arm on 26Apr2021 at 16:30 (at the age of 19-years-old), 1st dose, single for COVID-19 immunization. Medical history included left eye was blurry and wear glasses. Concomitant medications included loratadine (CLARITINE), vitamin B complex (VITAMIN B) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The vaccine was administered at public health department. On 27Apr2021 at 6:30, the patient's left arm hurt at injection site, then whole arm hurt, and then it felt weak and numb. On the same day of 27Apr2021 at 6:30, the patient's left leg felt tingly, then it felt weak and numb. Her left side of face felt kind of numb and the left eye was blurrier than normal. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Movement disorder, Muscular weakness, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Left arm hurt at injection site; Whole arm hurt; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb/Left side of face feels kind of numb; Left leg felt tingly now it feels weak and numb; Left eye is blurrier than normal; Left eye is blurrier than normal; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0170), via an unspecified route of administration in left arm on 26Apr2021 at 16:30 (at the age of 19-years-old), 1st dose, single for COVID-19 immunization. Medical history included left eye was blurry and wear glasses. Concomitant medications included loratadine (CLARITINE), vitamin B complex (VITAMIN B) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The vaccine was administered at public health department. On 27Apr2021 at 6:30, the patient's left arm hurt at injection site, then whole arm hurt, and then it felt weak and numb. On the same day of 27Apr2021 at 6:30, the patient's left leg felt tingly, then it felt weak and numb. Her left side of face felt kind of numb and the left eye was blurrier than normal. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Left arm hurt at injection site; Whole arm hurt; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb/Left side of face feels kind of numb; Left leg felt tingly now it feels weak and numb; Left eye is blurrier than normal; Left eye is blurrier than normal; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0170), via an unspecified route of administration in left arm on 26Apr2021 at 16:30 (at the age of 19-years-old), 1st dose, single for COVID-19 immunization. Medical history included left eye was blurry and wear glasses. Concomitant medications included loratadine (CLARITINE), vitamin B complex (VITAMIN B) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The vaccine was administered at public health department. On 27Apr2021 at 6:30, the patient's left arm hurt at injection site, then whole arm hurt, and then it felt weak and numb. On the same day of 27Apr2021 at 6:30, the patient's left leg felt tingly, then it felt weak and numb. Her left side of face felt kind of numb and the left eye was blurrier than normal. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Hypoaesthesia, Muscular weakness, Pain in extremity, Paraesthesia
Clinical narrative: Left arm hurt at injection site; Whole arm hurt; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb/Left side of face feels kind of numb; Left leg felt tingly now it feels weak and numb; Left eye is blurrier than normal; Left eye is blurrier than normal; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0170), via an unspecified route of administration in left arm on 26Apr2021 at 16:30 (at the age of 19-years-old), 1st dose, single for COVID-19 immunization. Medical history included left eye was blurry and wear glasses. Concomitant medications included loratadine (CLARITINE), vitamin B complex (VITAMIN B) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The vaccine was administered at public health department. On 27Apr2021 at 6:30, the patient's left arm hurt at injection site, then whole arm hurt, and then it felt weak and numb. On the same day of 27Apr2021 at 6:30, the patient's left leg felt tingly, then it felt weak and numb. Her left side of face felt kind of numb and the left eye was blurrier than normal. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain, Vision blurred
Clinical narrative: Left arm hurt at injection site; Whole arm hurt; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb; Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb/Left leg felt tingly now it feels weak and numb/Left side of face feels kind of numb; Left leg felt tingly now it feels weak and numb; Left eye is blurrier than normal; Left eye is blurrier than normal; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EW0170), via an unspecified route of administration in left arm on 26Apr2021 at 16:30 (at the age of 19-years-old), 1st dose, single for COVID-19 immunization. Medical history included left eye was blurry and wear glasses. Concomitant medications included loratadine (CLARITINE), vitamin B complex (VITAMIN B) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The vaccine was administered at public health department. On 27Apr2021 at 6:30, the patient's left arm hurt at injection site, then whole arm hurt, and then it felt weak and numb. On the same day of 27Apr2021 at 6:30, the patient's left leg felt tingly, then it felt weak and numb. Her left side of face felt kind of numb and the left eye was blurrier than normal. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Pharyngeal swelling, Rash
Clinical narrative: 10 mins. after shot: Hot flash/flush full body, 20-30 mins. after shot rash, hives, shortness of breath, tightening of throat.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Flushing, Hot flush, Rash, Throat tightness
Clinical narrative: 10 mins. after shot: Hot flash/flush full body, 20-30 mins. after shot rash, hives, shortness of breath, tightening of throat.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: 10 mins. after shot: Hot flash/flush full body, 20-30 mins. after shot rash, hives, shortness of breath, tightening of throat.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Decreased appetite, Dehydration, Diarrhoea, Kidney infection
Clinical narrative: Pt experienced nausea , vomiting , diarrhea. Pt went to the hospital with kidney infection and UTI for 6 days. Pt has chronic migraine.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Migraine, Nausea, Urinary tract infection, Vomiting
Clinical narrative: Pt experienced nausea , vomiting , diarrhea. Pt went to the hospital with kidney infection and UTI for 6 days. Pt has chronic migraine.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Kidney infection, Migraine, Nausea, Urinary tract infection
Clinical narrative: Pt experienced nausea , vomiting , diarrhea. Pt went to the hospital with kidney infection and UTI for 6 days. Pt has chronic migraine.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Pt experienced nausea , vomiting , diarrhea. Pt went to the hospital with kidney infection and UTI for 6 days. Pt has chronic migraine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Migraine
Clinical narrative: vomiting; severe headache; tired; screaming in pain from the migraine; severe headache causing vomiting  which he described as migraine; chills; This is a spontaneous report from a contactable consumer or other non hcp.   A 39-years-old female patient received bnt162b2 (Formulation: Solution for injection), dose 1 via an unspecified route of administration on 27Apr2021 (Lot Number: EW0171) as 1ST DOSE, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced chills, severe headache causing vomiting  which he described as migraine, vomiting, severe headache, tired and screaming in pain from the migraine on 29Apr2021. Therapeutic measures were taken as a result of chills, severe headache causing vomiting  which he described as migraine , vomiting , severe headache, tired and screaming in pain from the migraine. Caller states his wife has experienced chills, fatigue, vomiting, and severe migraine. states his wife has been treating her symptoms with Ibuprofen, that has worked, it helps her feel better and do stuff during the day but feels worse at night. Caller states his wife took a shower on Monday and again last night and the hot temperature from the shower made her migraine much worse. This has happened now twice. States she basically collapsed in the shower, screaming in pain from the migraine, fits of vomiting. Thinks the chills have gone away. Exact dates not provided. The outcome of the e events chills, vomiting, severe headache was unknown and for other events was not resolved.    No follow-up attempts are needed. No further information is expected
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: vomiting; severe headache; tired; screaming in pain from the migraine; severe headache causing vomiting  which he described as migraine; chills; This is a spontaneous report from a contactable consumer or other non hcp.   A 39-years-old female patient received bnt162b2 (Formulation: Solution for injection), dose 1 via an unspecified route of administration on 27Apr2021 (Lot Number: EW0171) as 1ST DOSE, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced chills, severe headache causing vomiting  which he described as migraine, vomiting, severe headache, tired and screaming in pain from the migraine on 29Apr2021. Therapeutic measures were taken as a result of chills, severe headache causing vomiting  which he described as migraine , vomiting , severe headache, tired and screaming in pain from the migraine. Caller states his wife has experienced chills, fatigue, vomiting, and severe migraine. states his wife has been treating her symptoms with Ibuprofen, that has worked, it helps her feel better and do stuff during the day but feels worse at night. Caller states his wife took a shower on Monday and again last night and the hot temperature from the shower made her migraine much worse. This has happened now twice. States she basically collapsed in the shower, screaming in pain from the migraine, fits of vomiting. Thinks the chills have gone away. Exact dates not provided. The outcome of the e events chills, vomiting, severe headache was unknown and for other events was not resolved.    No follow-up attempts are needed. No further information is expected
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Migraine, Pain
Clinical narrative: vomiting; severe headache; tired; screaming in pain from the migraine; severe headache causing vomiting  which he described as migraine; chills; This is a spontaneous report from a contactable consumer or other non hcp.   A 39-years-old female patient received bnt162b2 (Formulation: Solution for injection), dose 1 via an unspecified route of administration on 27Apr2021 (Lot Number: EW0171) as 1ST DOSE, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced chills, severe headache causing vomiting  which he described as migraine, vomiting, severe headache, tired and screaming in pain from the migraine on 29Apr2021. Therapeutic measures were taken as a result of chills, severe headache causing vomiting  which he described as migraine , vomiting , severe headache, tired and screaming in pain from the migraine. Caller states his wife has experienced chills, fatigue, vomiting, and severe migraine. states his wife has been treating her symptoms with Ibuprofen, that has worked, it helps her feel better and do stuff during the day but feels worse at night. Caller states his wife took a shower on Monday and again last night and the hot temperature from the shower made her migraine much worse. This has happened now twice. States she basically collapsed in the shower, screaming in pain from the migraine, fits of vomiting. Thinks the chills have gone away. Exact dates not provided. The outcome of the e events chills, vomiting, severe headache was unknown and for other events was not resolved.    No follow-up attempts are needed. No further information is expected
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Dizziness, Dyspnoea, Hypersensitivity, Nausea
Clinical narrative: Following the first dose of the Pfizer vaccine, the patient reported to our medical tent with complaints of nausea and stomach discomfort.  During assessment, she developed new complaints of throat itching, tongue and facial swelling, and voice changes.  The provider onsite administered diphenhydramine 25mg IM at 1340, epi 0.3mg IM at 1343 with some resolution of symptoms.  Patient reported symptoms again at 1348 so an additional epi 0.3mg IM and diphenhydramine 25mg IM given.  EMS onsite at 1350 and patient was transported to local emergency room.  ED room notes describe the following:  BP=123/84, HR=75, Temp=36.8, RR=19, O2Sat=98%, EKG normal, Troponin <0.02.  Notes are limited.  Patient reported ongoing throat swelling.  RN noted that oral cavity visualized with no swelling observed.  HR up to 125 with patient complaints of heart 'racing,' reassurance provided.  Patient discharged to home following several hours of observation and a primary diagnosis of 'allergic reaction.'
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: Following the first dose of the Pfizer vaccine, the patient reported to our medical tent with complaints of nausea and stomach discomfort.  During assessment, she developed new complaints of throat itching, tongue and facial swelling, and voice changes.  The provider onsite administered diphenhydramine 25mg IM at 1340, epi 0.3mg IM at 1343 with some resolution of symptoms.  Patient reported symptoms again at 1348 so an additional epi 0.3mg IM and diphenhydramine 25mg IM given.  EMS onsite at 1350 and patient was transported to local emergency room.  ED room notes describe the following:  BP=123/84, HR=75, Temp=36.8, RR=19, O2Sat=98%, EKG normal, Troponin <0.02.  Notes are limited.  Patient reported ongoing throat swelling.  RN noted that oral cavity visualized with no swelling observed.  HR up to 125 with patient complaints of heart 'racing,' reassurance provided.  Patient discharged to home following several hours of observation and a primary diagnosis of 'allergic reaction.'
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Dysphonia, Hypersensitivity, Nausea, Palpitations
Clinical narrative: Following the first dose of the Pfizer vaccine, the patient reported to our medical tent with complaints of nausea and stomach discomfort.  During assessment, she developed new complaints of throat itching, tongue and facial swelling, and voice changes.  The provider onsite administered diphenhydramine 25mg IM at 1340, epi 0.3mg IM at 1343 with some resolution of symptoms.  Patient reported symptoms again at 1348 so an additional epi 0.3mg IM and diphenhydramine 25mg IM given.  EMS onsite at 1350 and patient was transported to local emergency room.  ED room notes describe the following:  BP=123/84, HR=75, Temp=36.8, RR=19, O2Sat=98%, EKG normal, Troponin <0.02.  Notes are limited.  Patient reported ongoing throat swelling.  RN noted that oral cavity visualized with no swelling observed.  HR up to 125 with patient complaints of heart 'racing,' reassurance provided.  Patient discharged to home following several hours of observation and a primary diagnosis of 'allergic reaction.'
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Swollen tongue, Throat irritation, Throat tightness, Troponin
Clinical narrative: Following the first dose of the Pfizer vaccine, the patient reported to our medical tent with complaints of nausea and stomach discomfort.  During assessment, she developed new complaints of throat itching, tongue and facial swelling, and voice changes.  The provider onsite administered diphenhydramine 25mg IM at 1340, epi 0.3mg IM at 1343 with some resolution of symptoms.  Patient reported symptoms again at 1348 so an additional epi 0.3mg IM and diphenhydramine 25mg IM given.  EMS onsite at 1350 and patient was transported to local emergency room.  ED room notes describe the following:  BP=123/84, HR=75, Temp=36.8, RR=19, O2Sat=98%, EKG normal, Troponin <0.02.  Notes are limited.  Patient reported ongoing throat swelling.  RN noted that oral cavity visualized with no swelling observed.  HR up to 125 with patient complaints of heart 'racing,' reassurance provided.  Patient discharged to home following several hours of observation and a primary diagnosis of 'allergic reaction.'
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Nausea and flushing/sweat
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Migraine, Pain, Pyrexia, Sleep disorder
Clinical narrative: Nausea and flushing/sweat
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Nausea and flushing/sweat
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Flushing, Hyperhidrosis, Nausea
Clinical narrative: Nausea and flushing/sweat
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Magnetic resonance imaging head, Magnetic resonance imaging head abnormal, Pain, Sensory loss
Clinical narrative: acute ischemic stroke left thalamus.  Right sided numbness.  Began hours after receiving second vaccination dose
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thalamic infarction
Clinical narrative: acute ischemic stroke left thalamus.  Right sided numbness.  Began hours after receiving second vaccination dose
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ischaemic stroke, Magnetic resonance imaging head abnormal
Clinical narrative: acute ischemic stroke left thalamus.  Right sided numbness.  Began hours after receiving second vaccination dose
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). This 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 10Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported.  The patient had a positive COVID-19 test on 20Apr2021 with outcome of unknown. The event was considered as non-serious. She was scheduled to get the second dose on 01May2021.  The information on the batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). This 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 10Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported.  The patient had a positive COVID-19 test on 20Apr2021 with outcome of unknown. The event was considered as non-serious. She was scheduled to get the second dose on 01May2021.  The information on the batch number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pain, General physical condition abnormal, Injection site pain, Jaw disorder, Neck pain
Clinical narrative: Bells Palsy
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in jaw, Speech disorder, Swelling
Clinical narrative: Bells Palsy
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy
Clinical narrative: Bells Palsy
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Herpes zoster
Clinical narrative: shingles on his face and around his eye/ has shingles on his eye; eye irritation; This is a spontaneous report from a contactable consumer (patient) and via a Pfizer program. A 67-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 67-years-old), administered in Arm Left on 01Mar2021 09:00 (Lot Number: EN6202) as 1st dose, single for COVID-19 immunization; and ibuprofen, route of administration, start and stop date, batch/lot number and dose were not reported for pain. The patient medical history was not reported. There were no concomitant medications. The patient experienced shingles on his face and around his eye/ has shingles on his eye and eye irritation on Mar2021. The patient requested information on the use of OTC pain relievers like Ibuprofen and the Pfizer-BioNTech COVID-19 Vaccine because he read some articles on this topic and asked how far before would he need to wait to take ibuprofen, he stated: "I'm scheduled for second vaccine tomorrow (29Mar2021, confirmed it is second dose of Pfizer-BioNTech COVID-19 Vaccine. First dose was received on 01Mar2021). I don't take Ibuprofen on a regular basis, only take it when I need it because I have a medical condition causing some pain, last time I took it was the day before yesterday and I won't take any today. Stated he got his first dose of the vaccine on 01Mar2021. Patient stated that he was prescribed the eye drops for shingles on his face and around his eye. They are for the eye irritation. Diagnosed with shingles either this past Monday, Tuesday, or Wednesday; uncertain of which day (unspecified date in Mar2021). He is asking if he can take painkillers after the second dose that because he has shingles on his eye. The action taken in response to the events for ibuprofen was unknown. Therapeutic measures were taken as a result of the events. The outcome of the events was unknown. The events were considered as serious. The second dose scheduled for 29Mar2021. The patient wanted to know if he can take his shot while on these Fluorometholone eye drops. No Prior Vaccinations (within 4 weeks).
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Eye irritation, Ophthalmic herpes zoster
Clinical narrative: shingles on his face and around his eye/ has shingles on his eye; eye irritation; This is a spontaneous report from a contactable consumer (patient) and via a Pfizer program. A 67-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 67-years-old), administered in Arm Left on 01Mar2021 09:00 (Lot Number: EN6202) as 1st dose, single for COVID-19 immunization; and ibuprofen, route of administration, start and stop date, batch/lot number and dose were not reported for pain. The patient medical history was not reported. There were no concomitant medications. The patient experienced shingles on his face and around his eye/ has shingles on his eye and eye irritation on Mar2021. The patient requested information on the use of OTC pain relievers like Ibuprofen and the Pfizer-BioNTech COVID-19 Vaccine because he read some articles on this topic and asked how far before would he need to wait to take ibuprofen, he stated: "I'm scheduled for second vaccine tomorrow (29Mar2021, confirmed it is second dose of Pfizer-BioNTech COVID-19 Vaccine. First dose was received on 01Mar2021). I don't take Ibuprofen on a regular basis, only take it when I need it because I have a medical condition causing some pain, last time I took it was the day before yesterday and I won't take any today. Stated he got his first dose of the vaccine on 01Mar2021. Patient stated that he was prescribed the eye drops for shingles on his face and around his eye. They are for the eye irritation. Diagnosed with shingles either this past Monday, Tuesday, or Wednesday; uncertain of which day (unspecified date in Mar2021). He is asking if he can take painkillers after the second dose that because he has shingles on his eye. The action taken in response to the events for ibuprofen was unknown. Therapeutic measures were taken as a result of the events. The outcome of the events was unknown. The events were considered as serious. The second dose scheduled for 29Mar2021. The patient wanted to know if he can take his shot while on these Fluorometholone eye drops. No Prior Vaccinations (within 4 weeks).
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Audiogram abnormal, Deafness unilateral, Dysphagia, Headache, Myringotomy
Clinical narrative: Patient developed sudden right sided hearing loss/pressure, vertigo, nausea, and phonophobia starting five hours after Moderna #2 on 29 March 2021. She was seen on 22 April by Audiology and ENT specialists, found to have a mixed conductive/sensorineural (mostly conductive) hearing loss (Type B tympanogram), unilateral right ear. Treated with Methylprednisolone taper pak without improvement in hearing. Seen again on 29 April 2021, again with Type B tympanogram; attempted myringotomy without return of fluid. Patient continues to have right sided conductive hearing loss and pressure sensation, dizziness, and periodic nausea. No improvement in ear pressure at this time. Starting approximately 10 April 2021, patient reports difficulty swallowing water and managing her oral secretions; she says the fluid will start to go towards the windpipe and she will have to cough and more deliberately swallow to ensure it goes down the esophagus.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Salivary hypersecretion, Tympanometry
Clinical narrative: Patient developed sudden right sided hearing loss/pressure, vertigo, nausea, and phonophobia starting five hours after Moderna #2 on 29 March 2021. She was seen on 22 April by Audiology and ENT specialists, found to have a mixed conductive/sensorineural (mostly conductive) hearing loss (Type B tympanogram), unilateral right ear. Treated with Methylprednisolone taper pak without improvement in hearing. Seen again on 29 April 2021, again with Type B tympanogram; attempted myringotomy without return of fluid. Patient continues to have right sided conductive hearing loss and pressure sensation, dizziness, and periodic nausea. No improvement in ear pressure at this time. Starting approximately 10 April 2021, patient reports difficulty swallowing water and managing her oral secretions; she says the fluid will start to go towards the windpipe and she will have to cough and more deliberately swallow to ensure it goes down the esophagus.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Audiogram, Cough, Deafness unilateral, Dizziness
Clinical narrative: Patient developed sudden right sided hearing loss/pressure, vertigo, nausea, and phonophobia starting five hours after Moderna #2 on 29 March 2021. She was seen on 22 April by Audiology and ENT specialists, found to have a mixed conductive/sensorineural (mostly conductive) hearing loss (Type B tympanogram), unilateral right ear. Treated with Methylprednisolone taper pak without improvement in hearing. Seen again on 29 April 2021, again with Type B tympanogram; attempted myringotomy without return of fluid. Patient continues to have right sided conductive hearing loss and pressure sensation, dizziness, and periodic nausea. No improvement in ear pressure at this time. Starting approximately 10 April 2021, patient reports difficulty swallowing water and managing her oral secretions; she says the fluid will start to go towards the windpipe and she will have to cough and more deliberately swallow to ensure it goes down the esophagus.